Atomization efficacy of a novel micro-dose mesh nebulizer (CVS-100) versus the traditional mesh nebulizer (M102) in adults with chronic obstructive pulmonary disease: A randomized non-inferiority clinical trial
CONCLUSION: The novel micro-dose mesh nebulizer (CVS-100) was found to be non-inferior to the traditional mesh nebulizer (M102) in terms of the change in FEV1%pred from baseline after nebulization. Similar results were observed for all other measures of efficacy.PMID:37879448 | DOI:10.1016/j.rmed.2023.107434
Source: Respiratory Care - Category: Respiratory Medicine Authors: Yulan Qu Ying Gong Li Li Yansha Song Yuanlin Song Dongni Hou Lijuan Hu Source Type: research
More News: Chronic Obstructive Pulmonary | Clinical Trials | Combivent | Respiratory Medicine | Study